States / U.S. Congress / HR 8205
HR 8205 Passed First Chamber
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Jul 23, 2026 · Senate
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.
Jul 22, 2026 · House
Motion to reconsider laid on the table Agreed to without objection.
Jul 22, 2026 · House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Jul 22, 2026 · House
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Jul 22, 2026 · House
Considered as unfinished business. (consideration: CR H5159)
Jul 20, 2026 · House
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
Jul 20, 2026 · House
DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.
Jul 20, 2026 · House
Considered under suspension of the rules. (consideration: CR H4652-4654; text: CR H4653)
Jul 20, 2026 · House
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jul 9, 2026 · House
Placed on the Union Calendar, Calendar No. 637.
Jul 9, 2026 · House
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
May 21, 2026 · House
Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
May 21, 2026 · House
Committee Consideration and Mark-up Session Held
May 13, 2026 · House
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026 · House
Subcommittee Consideration and Mark-up Session Held
Apr 6, 2026 · House
Referred to the Subcommittee on Health.
Apr 6, 2026 · House
Referred to the House Committee on Energy and Commerce.
Apr 6, 2026 · House
Introduced in House